Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[1] 4-Anilino-pyrimidine, novel aldosterone synthase (CYP11B2) inhibitors bearing pyrimidine structures
Meguro, Masaki
Miyauchi, Satoru
Kanao, Yukiko
Naito, Satoru
Suzuki, Kanae
Inoue, Shinichi
Yamada, Keisuke
Homma, Tsuyoshi
Chiba, Kiyoshi
Nara, Futoshi
Furuzono, Shinji
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (09) : 1902 - 1906
[2] Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors
Sparks, Steven M.
Danger, Dana P.
Hoekstra, William J.
Leesnitzer, Tony
Schotzinger, Robert J.
Yates, Christopher M.
Becherer, J. David
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1056 - 1060
[3] Synthesis of annulated pyridines as inhibitors of aldosterone synthase (CYP11B2)
Martin, Rainer E.
Lehmann, Johannes
Alzieu, Thibaut
Lenz, Mario
Corrales, Marjorie A. Carnero
Aebi, Johannes D.
Marki, Hans Peter
Kuhn, Bernd
Amrein, Kurt
Mayweg, Alexander V.
Britton, Robert
ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (25) : 5922 - 5927
[4] Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2
Sakakibara, Ryo
Sasaki, Wataru
Onda, Yuichi
Yamaguchi, Minami
Ushirogochi, Hideki
Hiraga, Yuki
Sato, Kanako
Nishio, Masashi
Egi, Yasuhiro
Takedomi, Kei
Shimizu, Hidetoshi
Ohbora, Tomoko
Akahoshi, Fumihiko
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (13) : 5594 - 5608
[5] Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity
Meyers, Kenneth
Cogan, Derek A.
Burke, Jennifer
Arenas, Raquel
Balestra, Michael
Brown, Nicholas F.
Chen, Zhidong
Cerny, Matthew A.
Clifford, Holly E.
Colombo, Federico
Fader, Lee
Frederick, Kosea S.
Guo, Xin
Goldberg, Daniel
Hornberger, Keith R.
Kugler, Stanley
Lord, John
Marshall, Daniel R.
Moss, Neil
Parmentier, Jean-Huges
Richman, Jeremy R.
Schmenk, Jennifer
Weldon, Steven M.
Yu, Maolin
Zhang, Michael
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 979 - 984
[6] Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension
Hoyt, Scott B.
Taylor, Jerry
London, Clare
Ali, Amjad
Ujjainwalla, Feroze
Tata, Jim
Struthers, Mary
Cully, Doris
Wisniewski, Tom
Ren, Ning
Bopp, Charlene
Sok, Andrea
Verras, Andreas
McMasters, Daniel
Chen, Qing
Tung, Elaine
Tang, Wei
Salituro, Gino
Clemas, Joe
Zhou, Gaochao
MacNeil, Douglas
Duffy, Ruth
Xiong, Yusheng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2384 - 2388
[7] Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors
Meredith, Erik L.
Ksander, Gary
Monovich, Lauren G.
Papillon, Julien P. N.
Liu, Qian
Miranda, Karl
Morris, Patrick
Rao, Chang
Burgis, Robin
Capparelli, Michael
Hu, Qi-Ying
Singh, Alok
Rigel, Dean F.
Jeng, Arco Y.
Beil, Michael
Fu, Fumin
Hu, Chii-Whei
LaSala, Daniel
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (12): : 1203 - 1207
[8] N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)
Zimmer, Christina
Hafner, Marieke
Zender, Michael
Ammann, Dominic
Hartmann, Rolf W.
Vock, Carsten A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 186 - 190
[9] Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
Bogman, Katrijn
Schwab, Dietmar
Delporte, Marie-Laure
Palermo, Giuseppe
Amrein, Kurt
Mohr, Susanne
Mudry, Maria Cristina De Vera
Brown, Morris J.
Ferber, Philippe
HYPERTENSION, 2017, 69 (01) : 189 - 196
[10] Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
Takeda, Yoshimichi
Demura, Masashi
Kometani, Mitsuhiro
Karashima, Shigehiro
Yoneda, Takashi
Takeda, Yoshiyu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)

← 1 2 3 4 5 →